off label use of semaglutide Ozempic Goes Way Off-Label Trends in Off-Label Use from

Emulation of randomized clinical trials with nonrandomized database analyses: results of 32 clinical trials

Longer-term metabolic benefits, like improved insulin sensitivity, tend to build gradually with consistent dietary patterns

Further, a per-protocol analysis was performed on the basis of 31 patients who received all 3 injections in each trial phase

Not all individuals experience the same degree of weight regain

Sources Lilly TRIUMPH-1 topline release mirror with full PRNewswire text Axios, May 21, 2026: retatrutide reaches surgery-level weight loss ClinicalTrials.gov: TRIUMPH-1 (NCT05929066) Lilly TRIUMPH-4 official release, December 11, 2025 NEJM: Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial Lilly phase 2 retatrutide press release, June 26, 2023